Cell Therapy Market Size, Share & Industry Analysis by Therapy Type (CAR-T Cell Therapy, TCR-T Cell Therapy, Natural Killer (NK) Cells, and Others), By Product (Kymriah, Yescarta, Tecartus, Breyanzi, Abecma, Carvykti, and Others), By Indication (Oncology and Others), By End User (Hospitals & Clinics, Specialty Clinics, and Others), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI114224

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Overview: Advancements in of Cell Therapy for New Disease Indications
2. Regulatory Scenarios, By Key Countries/Regions
3. Technological Advancements in the Market
4. New Product Launches, By Key Players
5. Pipeline Analysis, By Key Companies
6. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, and Others)
7. Pricing & Reimbursement Landscape in the Market
8. Manufacturing & Supply Chain Insights
9. Investment & Funding Trends in the Market
Global Cell Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Therapy Type
  1. CAR-T Cell Therapy
  2. TCR-T Cell Therapy
  3. Natural Killer (NK) Cells
  4. Others
2. Market Analysis, Insights and Forecast – By Product
  1. Kymriah
  2. Yescarta
  3. Tecartus
  4. Breyanzi
  5. Abecma
  6. Carvykti
  7. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Cell Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Therapy Type
  1. CAR-T Cell Therapy
  2. TCR-T Cell Therapy
  3. Natural Killer (NK) Cells
  4. Others
2. Market Analysis, Insights and Forecast – By Product
  1. Kymriah
  2. Yescarta
  3. Tecartus
  4. Breyanzi
  5. Abecma
  6. Carvykti
  7. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Cell Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Therapy Type
  1. CAR-T Cell Therapy
  2. TCR-T Cell Therapy
  3. Natural Killer (NK) Cells
  4. Others
2. Market Analysis, Insights and Forecast – By Product
  1. Kymriah
  2. Yescarta
  3. Tecartus
  4. Breyanzi
  5. Abecma
  6. Carvykti
  7. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Cell Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Therapy Type
  1. CAR-T Cell Therapy
  2. TCR-T Cell Therapy
  3. Natural Killer (NK) Cells
  4. Others
2. Market Analysis, Insights and Forecast – By Product
  1. Kymriah
  2. Yescarta
  3. Tecartus
  4. Breyanzi
  5. Abecma
  6. Carvykti
  7. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Cell Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Therapy Type
  1. CAR-T Cell Therapy
  2. TCR-T Cell Therapy
  3. Natural Killer (NK) Cells
  4. Others
2. Market Analysis, Insights and Forecast – By Product
  1. Kymriah
  2. Yescarta
  3. Tecartus
  4. Breyanzi
  5. Abecma
  6. Carvykti
  7. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Cell Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Therapy Type
  1. CAR-T Cell Therapy
  2. TCR-T Cell Therapy
  3. Natural Killer (NK) Cells
  4. Others
2. Market Analysis, Insights and Forecast – By Product
  1. Kymriah
  2. Yescarta
  3. Tecartus
  4. Breyanzi
  5. Abecma
  6. Carvykti
  7. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability)
  1. Novartis AG
  2. Gilead Sciences, Inc.
  3. Bristol Myers Squibb Company
  4. Johnson & Johnson
  5. Vertex Pharmaceuticals Incorporated
  6. Bayer AG
  7. Adaptimmune
  8. IOVANCE Biotherapeutics, Inc.
  9. F. Hoffmann-La Roche Ltd
  10. Fate Therapeutics

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Overview: Advancements in of Cell Therapy for New Disease Indications
2. Regulatory Scenarios, By Key Countries/Regions
3. Technological Advancements in the Market
4. New Product Launches, By Key Players
5. Pipeline Analysis, By Key Companies
6. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, and Others)
7. Pricing & Reimbursement Landscape in the Market
8. Manufacturing & Supply Chain Insights
9. Investment & Funding Trends in the Market
Global Cell Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Therapy Type
  1. CAR-T Cell Therapy
  2. TCR-T Cell Therapy
  3. Natural Killer (NK) Cells
  4. Others
2. Market Analysis, Insights and Forecast – By Product
  1. Kymriah
  2. Yescarta
  3. Tecartus
  4. Breyanzi
  5. Abecma
  6. Carvykti
  7. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Cell Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Therapy Type
  1. CAR-T Cell Therapy
  2. TCR-T Cell Therapy
  3. Natural Killer (NK) Cells
  4. Others
2. Market Analysis, Insights and Forecast – By Product
  1. Kymriah
  2. Yescarta
  3. Tecartus
  4. Breyanzi
  5. Abecma
  6. Carvykti
  7. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Cell Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Therapy Type
  1. CAR-T Cell Therapy
  2. TCR-T Cell Therapy
  3. Natural Killer (NK) Cells
  4. Others
2. Market Analysis, Insights and Forecast – By Product
  1. Kymriah
  2. Yescarta
  3. Tecartus
  4. Breyanzi
  5. Abecma
  6. Carvykti
  7. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Cell Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Therapy Type
  1. CAR-T Cell Therapy
  2. TCR-T Cell Therapy
  3. Natural Killer (NK) Cells
  4. Others
2. Market Analysis, Insights and Forecast – By Product
  1. Kymriah
  2. Yescarta
  3. Tecartus
  4. Breyanzi
  5. Abecma
  6. Carvykti
  7. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Cell Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Therapy Type
  1. CAR-T Cell Therapy
  2. TCR-T Cell Therapy
  3. Natural Killer (NK) Cells
  4. Others
2. Market Analysis, Insights and Forecast – By Product
  1. Kymriah
  2. Yescarta
  3. Tecartus
  4. Breyanzi
  5. Abecma
  6. Carvykti
  7. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Cell Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Therapy Type
  1. CAR-T Cell Therapy
  2. TCR-T Cell Therapy
  3. Natural Killer (NK) Cells
  4. Others
2. Market Analysis, Insights and Forecast – By Product
  1. Kymriah
  2. Yescarta
  3. Tecartus
  4. Breyanzi
  5. Abecma
  6. Carvykti
  7. Others
3. Market Analysis, Insights and Forecast – By Indication
  1. Oncology
  2. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability)
  1. Novartis AG
  2. Gilead Sciences, Inc.
  3. Bristol Myers Squibb Company
  4. Johnson & Johnson
  5. Vertex Pharmaceuticals Incorporated
  6. Bayer AG
  7. Adaptimmune
  8. IOVANCE Biotherapeutics, Inc.
  9. F. Hoffmann-La Roche Ltd
  10. Fate Therapeutics

Read Less

List of Figures

Figure 1: Global Cell Therapy Market Revenue Breakdown (USD Billion, %) by Region, 2024 & 2032

Figure 2: Global Cell Therapy Market Value Share (%), By Therapy Type, 2024 & 2032

Figure 3: Global Cell Therapy Market Value Share (%), By Product, 2024 & 2032

Figure 4: Global Cell Therapy Market Value Share (%), By Indication, 2024 & 2032

Figure 5: Global Cell Therapy Market Value Share (%), By End User, 2024 & 2032

Figure 6: Global Cell Therapy Market Value (USD Billion), by Region, 2024 & 2032

Figure 7: North America Cell Therapy Market Value (USD Billion), By Therapy Type, 2024 & 2032

Figure 8: North America Cell Therapy Market Value Share (%), By Therapy Type, 2024

Figure 9: North America Cell Therapy Market Value (USD Billion), By Product, 2024 & 2032

Figure 10: North America Cell Therapy Market Value Share (%), By Product, 2024

Figure 11: North America Cell Therapy Market Value (USD Billion), By Indication, 2024 & 2032

Figure 12: North America Cell Therapy Market Value Share (%), By Indication, 2024

Figure 13: North America Cell Therapy Market Value (USD Billion), By End User, 2024 & 2032

Figure 14: North America Cell Therapy Market Value Share (%), By End User, 2024

Figure 15: North America Cell Therapy Market Value (USD Billion), By Country, 2024 & 2032

Figure 16: North America Cell Therapy Market Value Share (%), By Country, 2024

Figure 17: Europe Cell Therapy Market Value (USD Billion), By Therapy Type, 2024 & 2032

Figure 18: Europe Cell Therapy Market Value Share (%), By Therapy Type, 2024

Figure 19: Europe Cell Therapy Market Value (USD Billion), By Product, 2024 & 2032

Figure 20: Europe Cell Therapy Market Value Share (%), By Product, 2024

Figure 21: Europe Cell Therapy Market Value (USD Billion), By Indication, 2024 & 2032

Figure 22: Europe Cell Therapy Market Value Share (%), By Indication, 2024

Figure 23: Europe Cell Therapy Market Value (USD Billion), By End User, 2024 & 2032

Figure 24: Europe Cell Therapy Market Value Share (%), By End User, 2024

Figure 25: Europe Cell Therapy Market Value (USD Billion), By Country/ Sub-region, 2024 & 2032

Figure 26: Europe Cell Therapy Market Value Share (%), By Country/ Sub-region, 2024

Figure 27: Asia Pacific Cell Therapy Market Value (USD Billion), By Therapy Type, 2024 & 2032

Figure 28: Asia Pacific Cell Therapy Market Value Share (%), By Therapy Type, 2024

Figure 29: Asia Pacific Cell Therapy Market Value (USD Billion), By Product, 2024 & 2032

Figure 30: Asia Pacific Cell Therapy Market Value Share (%), By Product, 2024

Figure 31: Asia Pacific Cell Therapy Market Value (USD Billion), By Indication, 2024 & 2032

Figure 32: Asia Pacific Cell Therapy Market Value Share (%), By Indication, 2024

Figure 33: Asia Pacific Cell Therapy Market Value (USD Billion), By End User, 2024 & 2032

Figure 34: Asia Pacific Cell Therapy Market Value Share (%), By End User, 2024

Figure 35: Asia Pacific Cell Therapy Market Value (USD Billion), By Country/ Sub-region, 2024 & 2032

Figure 36: Asia Pacific Cell Therapy Market Value Share (%), By Country/ Sub-region, 2024

Figure 37: Latin America Cell Therapy Market Value (USD Billion), By Therapy Type, 2024 & 2032

Figure 38: Latin America Cell Therapy Market Value Share (%), By Therapy Type, 2024

Figure 39: Latin America Cell Therapy Market Value (USD Billion), By Product, 2024 & 2032

Figure 40: Latin America Cell Therapy Market Value Share (%), By Product, 2024

Figure 41: Latin America Cell Therapy Market Value (USD Billion), By Indication, 2024 & 2032

Figure 42: Latin America Cell Therapy Market Value Share (%), By Indication, 2024

Figure 43: Latin America Cell Therapy Market Value (USD Billion), By End User, 2024 & 2032

Figure 44: Latin America Cell Therapy Market Value Share (%), By End User, 2024

Figure 45: Latin America Cell Therapy Market Value (USD Billion), By Country/ Sub-region, 2024 & 2032

Figure 46: Latin America Cell Therapy Market Value Share (%), By Country/ Sub-region, 2024

Figure 47: Middle East & Africa Cell Therapy Market Value (USD Billion), By Therapy Type, 2024 & 2032

Figure 48: Middle East & Africa Cell Therapy Market Value Share (%), By Therapy Type, 2024

Figure 49: Middle East & Africa Cell Therapy Market Value (USD Billion), By Product, 2024 & 2032

Figure 50: Middle East & Africa Cell Therapy Market Value Share (%), By Product, 2024

Figure 51: Middle East & Africa Cell Therapy Market Value (USD Billion), By Indication, 2024 & 2032

Figure 52: Middle East & Africa Cell Therapy Market Value Share (%), By Indication, 2024

Figure 53: Middle East & Africa Cell Therapy Market Value (USD Billion), By End User, 2024 & 2032

Figure 54: Middle East & Africa Cell Therapy Market Value Share (%), By End User, 2024

Figure 55: Middle East & Africa Cell Therapy Market Value (USD Billion), By Country/ Sub-region, 2024 & 2032

Figure 56: Middle East & Africa Cell Therapy Market Value Share (%), By Country/ Sub-region, 2024

Figure 57: Global Cell Therapy Market Share (%), By Company, 2024

List of Tables

Table 1: Global Cell Therapy Market Revenue (USD Billion) Forecast, By Therapy Type, 2019–2032

Table 2: Global Cell Therapy Market Revenue (USD Billion) Forecast, By Product, 2019–2032

Table 3: Global Cell Therapy Market Revenue (USD Billion) Forecast, By Indication, 2019–2032

Table 4: Global Cell Therapy Market Revenue (USD Billion) Forecast, By End User, 2019–2032

Table 5: Global Cell Therapy Market Revenue (USD Billion) Forecast, by Region, 2019-2032

Table 6: North America Cell Therapy Market Revenue (USD Billion) Forecast, By Therapy Type, 2019-2032

Table 7: North America Cell Therapy Market Revenue (USD Billion) Forecast, By Product, 2019-2032

Table 8: North America Cell Therapy Market Revenue (USD Billion) Forecast, By Indication, 2019–2032

Table 9: North America Cell Therapy Market Revenue (USD Billion) Forecast, By End User, 2019-2032

Table 10: North America Cell Therapy Market Revenue (USD Billion) Forecast, By Country, 2019-2032

Table 11: Europe Cell Therapy Market Revenue (USD Billion) Forecast, By Therapy Type, 2019-2032

Table 12: Europe Cell Therapy Market Revenue (USD Billion) Forecast, By Product, 2019-2032

Table 13: Europe Cell Therapy Market Revenue (USD Billion) Forecast, By Indication, 2019–2032

Table 14: Europe Cell Therapy Market Revenue (USD Billion) Forecast, By End User, 2019-2032

Table 15: Europe Cell Therapy Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2019-2032

Table 16: Asia Pacific Cell Therapy Market Revenue (USD Billion) Forecast, By Therapy Type, 2019-2032

Table 17: Asia Pacific Cell Therapy Market Revenue (USD Billion) Forecast, By Product, 2019-2032

Table 18: Asia Pacific Cell Therapy Market Revenue (USD Billion) Forecast, By Indication, 2019–2032

Table 19: Asia Pacific Cell Therapy Market Revenue (USD Billion) Forecast, By End User, 2019-2032

Table 20: Asia Pacific Cell Therapy Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2019-2032

Table 21: Latin America Cell Therapy Market Revenue (USD Billion) Forecast, By Therapy Type, 2019-2032

Table 22: Latin America Cell Therapy Market Revenue (USD Billion) Forecast, By Product, 2019-2032

Table 23: Latin America Cell Therapy Market Revenue (USD Billion) Forecast, By Indication, 2019–2032

Table 24: Latin America Cell Therapy Market Revenue (USD Billion) Forecast, By End User, 2019-2032

Table 25: Latin America Cell Therapy Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2019-2032

Table 26: Middle East & Africa Cell Therapy Market Revenue (USD Billion) Forecast, By Therapy Type, 2019-2032

Table 27: Middle East & Africa Cell Therapy Market Revenue (USD Billion) Forecast, By Product, 2019-2032

Table 28: Middle East & Africa Cell Therapy Market Revenue (USD Billion) Forecast, By Indication, 2019–2032

Table 29: Middle East & Africa Cell Therapy Market Revenue (USD Billion) Forecast, By End User, 2019-2032

Table 30: Middle East & Africa Cell Therapy Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2019-2032

STUDY PERIOD: 2019-2032
BASE YEAR: 2024
HISTORICAL DATA: 2019-2023
NO OF PAGES: 210

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com